US2019167759A1PendingUtilityA1

Antimicrobial compositions and methods of use thereof

Assignee: MOREHOUSE SCHOOL OF MEDICINEPriority: Oct 7, 2011Filed: Jan 7, 2019Published: Jun 6, 2019
Est. expiryOct 7, 2031(~5.2 yrs left)· nominal 20-yr term from priority
A61K 47/60C12N 7/00C07K 7/06A61K 38/08A61K 45/06A61K 38/162A61P 31/00C12N 2740/16032A61P 31/04Y02A50/475Y02A50/473Y02A50/478Y02A50/481Y02A50/49Y02A50/471Y02A50/401Y02A50/30
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present application discloses a method for treating microbial infection using an antimicrobial composition comprises antimicrobial peptide which contains at least one VGFPV motif.

Claims

exact text as granted — not AI-modified
1 . A method of treating a microbial infection, comprising:
 administering to a subject in need thereof an effective amount of an antimicrobial peptide comprising a first antimicrobial domain comprising at least two VGVSV (SEQ ID NO:2) motifs.   
     
     
         2 . The method of  claim 1 , wherein said antimicrobial peptide has a length of 10-200 amino acids. 
     
     
         3 . (canceled) 
     
     
         4 . The method of  claim 1 , wherein said antimicrobial peptide comprises at least one VGVSV motif at the N-terminal. 
     
     
         5 . The method of  claim 1 , wherein said antimicrobial peptide comprises at least one VGVSV motif at the C-terminal. 
     
     
         6 . The method of  claim 1 , wherein said antimicrobial peptide comprises the amino acid sequence of VGVSVAAVGVSV (SEQ ID NO:4). 
     
     
         7 . The method of  claim 1 , wherein said antimicrobial peptide further comprises a second antimicrobial domain, wherein said second antimicrobial domain is different from said first antimicrobial domain. 
     
     
         8 . The method of  claim 1 , wherein said antimicrobial peptide further comprises a cell penetrating peptide (CPP) domain. 
     
     
         9 . The method of  claim 1 , wherein said antimicrobial peptide further comprises a targeting domain. 
     
     
         10 . The method of  claim 1 , wherein said antimicrobial peptide is administered in combination with another antimicrobial agent. 
     
     
         11 . The method of  claim 10 , wherein said another antimicrobial agent is another antimicrobial peptide. 
     
     
         12 . The method of  claim 10 , wherein said another antimicrobial agent is an in vivo expression vector encoding said antimicrobial peptide. 
     
     
         13 . The method of  claim 10 , wherein said antimicrobial peptide is a PEGylated peptide. 
     
     
         14 - 18 . (canceled) 
     
     
         19 . A pharmaceutical composition for treating microbial infection, comprising:
 (1) an antimicrobial peptide comprising a first antimicrobial domain comprising two VGVSV (SEQ ID NO:2) motifs, and a cell penetrating peptide (CPP) domain and/or a targeting domain; and   (2) a pharmaceutically acceptable carrier.   
     
     
         20 . The pharmaceutical composition of  claim 19 , wherein said antimicrobial peptide is a PEGylated peptide. 
     
     
         21 . The pharmaceutical composition of  claim 19 , wherein said antimicrobial peptide further comprises a second antimicrobial domain, wherein said second antimicrobial domain is different from said first antimicrobial domain.

Join the waitlist — get patent alerts

Track US2019167759A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.